Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Direct application of siRNA for in vivo pain research.

Sarret P, Doré-Savard L, Beaudet N.

Methods Mol Biol. 2010;623:383-95. doi: 10.1007/978-1-60761-588-0_25.

PMID:
20217565
2.

RNA interference in pain research.

Röhl T, Kurreck J.

J Neurochem. 2006 Oct;99(2):371-80. Review.

3.

Antisense and RNA interference approaches to target validation in pain research.

Kurreck J.

Curr Opin Drug Discov Devel. 2004 Mar;7(2):179-87. Review.

PMID:
15603251
4.

Potential applications of siRNA for pain therapy.

Ganju P, Hall J.

Expert Opin Biol Ther. 2004 Apr;4(4):531-42. Review.

PMID:
15102602
5.

Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.

Aigner A.

J Biotechnol. 2006 Jun 25;124(1):12-25. Epub 2006 Jan 18. Review.

PMID:
16413079
6.

In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.

Malek A, Merkel O, Fink L, Czubayko F, Kissel T, Aigner A.

Toxicol Appl Pharmacol. 2009 Apr 1;236(1):97-108. doi: 10.1016/j.taap.2009.01.014. Epub 2009 Jan 29.

PMID:
19371615
7.

Rational design and in vitro and in vivo delivery of Dicer substrate siRNA.

Amarzguioui M, Lundberg P, Cantin E, Hagstrom J, Behlke MA, Rossi JJ.

Nat Protoc. 2006;1(2):508-17.

PMID:
17406276
8.

siRNA relieves chronic neuropathic pain.

Dorn G, Patel S, Wotherspoon G, Hemmings-Mieszczak M, Barclay J, Natt FJ, Martin P, Bevan S, Fox A, Ganju P, Wishart W, Hall J.

Nucleic Acids Res. 2004 Mar 16;32(5):e49.

9.

Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis.

Schiffelers RM, Xu J, Storm G, Woodle MC, Scaria PV.

Arthritis Rheum. 2005 Apr;52(4):1314-8.

10.

Therapeutic opportunities of small interfering RNA.

Goyal BR, Patel MM, Soni MK, Bhadada SV.

Fundam Clin Pharmacol. 2009 Aug;23(4):367-86. doi: 10.1111/j.1472-8206.2009.00694.x. Review.

PMID:
19709318
11.

Hydrodynamic delivery protocols.

Rychahou PG, Evers BM.

Methods Mol Biol. 2010;623:189-95. doi: 10.1007/978-1-60761-588-0_12.

PMID:
20217552
12.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
13.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
14.

Short interfering RNA (siRNA): tool or therapeutic?

Cejka D, Losert D, Wacheck V.

Clin Sci (Lond). 2006 Jan;110(1):47-58. Review.

PMID:
16336204
15.

Polyethylenimine (PEI)/siRNA-mediated gene knockdown in vitro and in vivo.

Höbel S, Aigner A.

Methods Mol Biol. 2010;623:283-97. doi: 10.1007/978-1-60761-588-0_18.

PMID:
20217558
16.

Ex vivo and in vivo delivery of anti-tissue factor short interfering RNA inhibits mouse pulmonary metastasis of B16 melanoma cells.

Amarzguioui M, Peng Q, Wiiger MT, Vasovic V, Babaie E, Holen T, Nesland JM, Prydz H.

Clin Cancer Res. 2006 Jul 1;12(13):4055-61.

17.

siRNA stabilization prolongs gene knockdown in primary T lymphocytes.

Mantei A, Rutz S, Janke M, Kirchhoff D, Jung U, Patzel V, Vogel U, Rudel T, Andreou I, Weber M, Scheffold A.

Eur J Immunol. 2008 Sep;38(9):2616-25. doi: 10.1002/eji.200738075.

18.

Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.

Bartlett DW, Davis ME.

Biotechnol Bioeng. 2007 Jul 1;97(4):909-21.

PMID:
17154307
19.

A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium.

Santel A, Aleku M, Keil O, Endruschat J, Esche V, Fisch G, Dames S, Löffler K, Fechtner M, Arnold W, Giese K, Klippel A, Kaufmann J.

Gene Ther. 2006 Aug;13(16):1222-34. Epub 2006 Apr 20.

PMID:
16625243
20.

In vivo application of RNA interference: from functional genomics to therapeutics.

Lu PY, Xie F, Woodle MC.

Adv Genet. 2005;54:117-42. Review.

PMID:
16096010

Supplemental Content

Support Center